Under the terms of the transaction, Tellabs shareholders will receive only $2.45 in cash for each share of Tellabs stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Tellabs for not acting in the Company's shareholders best interests in connection with the sale process. The transaction may undervalue the company and will result in a loss for many long term shareholders. Tellabs stock traded at $4.37 per share on January 24, 2012 and traded at $3.56 per share on November 30, 2012. In addition, an analyst has set a price target of $2.50 per share and Tellabs has a reported book value of $2.81 per share.

If you own shares of Tellabs and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com, by visiting http://brodsky-smith.com/661-tlab-tellabs-inc.html, or calling toll free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and case action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.